CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• EPS Cop. Y/Y Annual
Regencell Bioscience Holdings Limited  (NASDAQ: RGC)
 

RGC's EPS from Cont. Operations Growth by Quarter and Year

Regencell Bioscience Holdings Limited's EPS from Cont. Operations results by quarter and year

Download as CSV




RGC EPS from Cont. Operations (in $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December -0.72 -0.01 -0.02 0.00
3rd Quarter September 0.00 0.00 0.00 0.00
2nd Quarter June 0.00 0.00 0.00 0.00
1st Quarter March 0.00 0.00 0.00 0.00
FY   -0.72 -0.01 -0.02 0.00

RGCs Annual EPS from Cont. Operations
Regencell Bioscience Holdings Limited's EPS from Cont. Operations in the fiscal year 2025 $ -0.72
Regencell Bioscience Holdings Limited's EPS from Cont. Operations in the fiscal year 2023 $ -0.01
Regencell Bioscience Holdings Limited's EPS from Cont. Operations in the fiscal year 2022 $ -0.02
Regencell Bioscience Holdings Limited's EPS from Cont. Operations in the fiscal year 2021 $ 0.00
Regencell Bioscience Holdings Limited's EPS from Cont. Operations in the fiscal year 2017 $ 0.02




RGC EPS from Cont. Operations fourth quarter 2025 Y/Y Growth Comment
Regencell Bioscience Holdings Limited in the fourth quarter 2025 recorded EPS loss from Cont. Operations of $ -0.72 .

According to the results reported in the fourth quarter 2025, Regencell Bioscience Holdings Limited achieved the best EPS from Cont. Operations growth in Legal Cannabis industry. While Regencell Bioscience Holdings Limited' s EPS from Cont. Operations no change of 0% ranks overall at the positon no. in the fourth quarter 2025.


RGC EPS from Cont. Operations ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - - - -

Financial Statements
Regencell Bioscience Holdings Limited's fourth quarter 2025 EPS from Cont. Operations $ -0.72 RGC's Income Statement
Regencell Bioscience Holdings Limited's fourth quarter 2024 EPS from Cont. Operations $ -0.01 Quarterly RGC's Income Statement


RGC EPS from Cont. Operations (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   - - - -


Go to RGC financial reports >> Back to RGC Growth rate Comparisons >>


EPS from Cont. Operations fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Regencell Bioscience Holdings Limited's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RGC's IV. Quarter Q/Q EPS from Cont. Operations Comment


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RGC's IV. Quarter Q/Q EPS from Cont. Operations Comment


Regencell Bioscience Holdings Limited's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Jun 30 2023)		 12 Months Ending
0		 12 Months Ending
0		 12 Months Ending
0
Cumulative EPS from Cont. Operations 12 Months Ending $ -0.72 $ -0.01 $ 0.00 $ 0.00 $ 0.00
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #


Cumulative EPS from Cont. Operations growth Comment
Regencell Bioscience Holdings Limited' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -1 in the Jun 30 2025 period.
The business is worsening as the cumulative EPS loss from Cont. Operations is inflating from $ -0.01 for the period from Jun 30 2023 to 0 and $ from the TTM period ending 0.

Regencell Bioscience Holdings Limited achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment
Regencell Bioscience Holdings Limited' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -1 in the Jun 30 2025 period.
The business is worsening as the cumulative EPS loss from Cont. Operations is inflating from $ -0.01 for the period from Jun 30 2023 to 0 and $ from the TTM period ending 0.

Regencell Bioscience Holdings Limited achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other EPS from Cont. Operations Growth
Legal Cannabis Industry EPS from Cont. Operations Growth Trends and Statistics
Consumer Non Cyclical Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
RGC's EPS from Cont. Operations Growth Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth




Companies with similar EPS from Cont. Operations no change for the quarter ending Jun 30 2025 within Consumer Non Cyclical SectorY/Y Change %EPS from Cont. Operations for the quarter ending Jun 30 2025


About Regencell Bioscience Holdings Limited EPS from Cont. Operations Growth Rates (RGC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.